Efficacy of losartan vs. atenolol for the prevention of aortic dilation in Marfan syndrome: a randomized clinical trial

Design and rationale of a prospective, collaborative meta-analysis of all randomized controlled trials of angiotensin receptor antagonists in Marfan syndrome, based on individual patient data: A report from the Marfan Treatment Trialists' Collaboration

(2015) Alex Pitcher et al.   AMERICAN HEART JOURNAL

Dimorphic Effects of Transforming Growth Factor-β Signaling During Aortic Aneurysm Progression in Mice Suggest a Combinatorial Therapy for Marfan SyndromeSignificance

(2015) Jason R. Cook et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Beneficial Outcome of Losartan Therapy Depends on Type ofFBN1Mutation in Marfan SyndromeCLINICAL PERSPECTIVE

(2015) Romy Franken et al.   Circulation-Cardiovascular Genetics

Marfan Sartan: a randomized, double-blind, placebo-controlled trial

(2015) Olivier Milleron et al.   EUROPEAN HEART JOURNAL

Beneficial Outcome of Losartan Therapy Depends on Type ofFBN1Mutation in Marfan SyndromeCLINICAL PERSPECTIVE

(2015) Romy Franken et al.   Circulation-Cardiovascular Genetics

2014 ESC Guidelines on the diagnosis and treatment of aortic diseases

(2014)   EUROPEAN HEART JOURNAL

Atenolol versus Losartan in Children and Young Adults with Marfan's Syndrome

(2014) Ronald V. Lacro et al.   NEW ENGLAND JOURNAL OF MEDICINE

Usefulness of Losartan on the Size of the Ascending Aorta in an Unselected Cohort of Children, Adolescents, and Young Adults With Marfan Syndrome

(2013) Christiane Pees et al.   AMERICAN JOURNAL OF CARDIOLOGY

Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial

(2013) M. Groenink et al.   EUROPEAN HEART JOURNAL

Retrospective analysis of the effect of angiotensin II receptor blocker versus β-blocker on aortic root growth in paediatric patients with Marfan syndrome

(2013) Goetz C Mueller et al.   HEART

Losartan Added to β-Blockade Therapy for Aortic Root Dilation in Marfan Syndrome: A Randomized, Open-Label Pilot Study

(2013) Hsin-Hui Chiu et al.   MAYO CLINIC PROCEEDINGS

Aortic Event Rate in the Marfan Population

(2011) Guillaume Jondeau et al.   CIRCULATION

Angiotensin II Blockade and Aortic-Root Dilation in Marfan's Syndrome

(2008) Benjamin S. Brooke et al.   NEW ENGLAND JOURNAL OF MEDICINE